Brian Betts, MD

I am a physician-scientist and hold appointments in the Division of Hematology, Oncology, and Transplantation and the Masonic Cancer Center at the University of Minnesota. I received my internal medicine training here at the University of Minnesota and performed my training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center in Manhattan. My research blends efforts in the lab and clinic, to develop novel therapies for cancer patients. This work is focused on understanding and eliminating graft-versus-host disease while preserving, or even enhancing, the beneficial anti-tumor activity of the transplant. Clinically, my practice offers stem cell transplantation and immunotherapy services to patients with blood cell cancers. I also treat patients with graft-versus-host disease. As a physician, I greatly appreciate having the opportunity to offer innovative treatment options at the University of Minnesota and being a part of my patients’ recovery.

• University of Minnesota: Best Diagnostician Award, Internal Medicine Department (2007)
• Eastern Virginia Medical School: DRH Gourley Award for Excellence in Pharmacology (2004)
• Member, Alpha Omega Alpha (2003)
• Old Dominion University: Phi Eta Sigma Honors Society (2000)
• Omicron Delta Kappa Honors Society(1999)
• Phi Kappa Phi Honors Society (1999)
• Perfect Scholars List (1998-2000)
• Dean’s Lists (1997-2000)
• Honors College Stipend (1996-2000)
• External Sources: Amy Strelzer Manasevit Research Program Scholar (2016)
• ASBMT Transplant Clinical Research Training Course Scholar (2010)

• Society for Leukocyte Biology
• American Association of Immunologists
• American Society of Hematology
• Center for International Blood and Marrow Transplant Research (CIMBTR)
• American College of Physicians
• Alpha Omega Alpha         

• GVHD
• GVL, Immunotherapy
• Cell Signaling
• Tregs
• Tissue Rejection

• 1R01HL133823-01
  NIH/NHLBI
  PI: Brian C. Betts, MD
  Dates: 7/1/2016-6/30/2021
  Title: Targeting T-Cell costimulation and cytokine activation to prevent GVHD and preserve GVL 
• Amy Strelzer Manasevit Research Program Award
  NMDP PI: Brian C. Betts, MD
  Dates: 7/1/2016-6/30/2019
  Source: Amy Strelzer Manasevit Research Program
  Title: Adoptive transfer of antigen-specific, STAT3-inhibited iTreg to prevent GVHD and preserve GVL